Eric Kelsic

Company: Dyno Therapeutics

Job title: Co-Founder & Chief Executive Officer

Bio:

Prior to founding Dyno, Eric led a team to develop the technology underlying Dyno’s artificial intelligence powered capsid engineering platform in George Church’s lab at the Wyss Institute of Harvard Medical School. There he measured the first comprehensive fitness landscape of the adeno-associated virus (AAV) capsid protein and co-discovered the AAV MAAP gene.

Seminars:

Accelerating Clinical Impact with Novel AAV Vectors Designed for Enhanced Delivery to Eye, Muscle, & CNS 11:30 am

Applying AI to design AAV capsids with optimized transduction efficiency for eye, muscle, and CNS delivery to facilitate enhanced clinical outcomes Validating capsid performance in NHPs to ensure safety, efficacy, and effective translation of novel capsids Demonstrating delivery to specific cell populations to motivate accelerated development of more effective treatments for rare and common diseasesRead more

day: Conference Day One